Sökresultat

Ett stick i fingret är allt som krävs för att delta i studien Triad, som screenar skånska barn för tre besläktade sjukdomar. En tidig upptäckt av typ 1-diabetes, celiaki och tyreoidit är viktigt för att undvika allvarliga besvär. Målet med studien är att etablera effektiva screeningmetoder för de tre sjukdomarna. De autoimmuna sjukdomarna typ 1-diabetes, celiaki och tyreoidit är nära besläktade. E

https://www.medicin.lu.se/artikel/ny-studie-10-000-skanska-barn-erbjuds-test-tre-autoimmuna-sjukdomar - 2025-12-29

Årets Eric K. Fernströms pris till yngre, särskilt lovande och framgångsrika forskare vid Lunds universitet tilldelas i år Alexandru Schiopu, docent i kardiologi. Han får utmärkelsen och priset på 80 000 kronor för sin framstående forskning om immunsystemets roll vid hjärtsjukdom. Motivering till priset: "För hans framstående forskning om immunsystemets roll vid hjärtsjukdom, vilken på ett föredöm

https://www.medicin.lu.se/artikel/lunds-fernstromspris-forskning-som-forbattrar-behandling-av-hjartsjukdom - 2025-12-29

Jan Hains stiftelse för vetenskaplig klinisk medicinsk forskning tilldelar Jimmie Kristensson, universitetslektor vid medicinska fakulteten och vicerektor med ansvar för kommunikation, kurage och karaktär, sitt årliga stipendium. Stipendiesumma är 225 000 kr och avser forskningsprojektet ”Tidiga palliativa insatser för personer med matstrups- och magsäckscancer - ett underlag för att kunna ge bäst

https://www.medicin.lu.se/artikel/jan-hains-stipendium-till-jimmie-kristensson - 2025-12-29

Tillsammans med Kockska stiftelsen och Region Skåne anordnar Artrosportalen vid Lunds universitet ett kostnadsfritt webbseminarium med föreläsningar av några av Sveriges främsta forskare inom artros och demens. Webbseminariet äger rum den 6 oktober och kommer att följas av en modererad paneldiskussion med chatmöjlighet. Hallå där, Martin Englund, varför arrangerar ni ett webbinarium om artros och

https://www.medicin.lu.se/artikel/popularvetenskapligt-webbseminarium-om-artros-och-demens - 2025-12-29

Lina Boreson, operativ chef på Smile Incubator i Lund och extern ledamot i Medicinska fakultetens styrelse, tilldelas stipendiet ”Nästa skånska stjärna” som går till en person från ett företag i Sydsverige som står inför en skarp strategisk utmaning och kan spela en viktig roll i regionens utveckling. – Det är mycket hedrande och spännande, säger hon. Lina Boreson anser att fler innovationer måste

https://www.medicin.lu.se/artikel/satsning-ska-framja-innovationer-och-entreprenorskap-inom-life-science - 2025-12-29

Professor Peter Zygmunt beskriver en av årets Nobelpristagare David Julius som en väldigt öppen och nyfiken person som själv visade ett stort intresse för arbetet i laboratoriet. – Jag tror en framgångsfaktor är att själv delta och ha en närhet till sina medarbetare. Med amerikanska mått mätt har han haft ett ganska litet antal doktorander och postdoktorsstudenter. Kvantitet är inte detsamma som f

https://www.medicin.lu.se/artikel/nobelpris-forskning-om-jonkanaler-beroring-och-temperatur - 2025-12-29

På uppdrag av regeringen utvecklar och tillhandahåller SciLifeLab avancerade tekniker, instrument och kompetens till forskare inom akademin, industrin och sjukvården i hela Sverige. Sedan den 1 juni i år är Johan Malmström plattform Scientific Director vid Integrated Structural Biology, ISB, som är en av plattformarna inom SciLifeLab. Vad är plattformens uppdrag? – Plattformen kommer i samarbete m

https://www.medicin.lu.se/artikel/johan-malmstrom-science-director-plattform-vid-scilifelab - 2025-12-29

Researchers from Lund Stem Cell Center highlight the importance of controlling viral elements that reside in the genome and how their activation during development may contribute to brain disorders later in life. Around 10% of the human genome is composed of DNA sequences originating from viruses that infected our ancestors throughout the millions of years of our evolution. Under normal conditions

https://www.multipark.lu.se/article/activation-ancient-viruses-during-brain-development-causes-inflammation - 2025-12-29

During her PhD studies Shelby Shrigley has been exploring patient-specific cell replacement therapy for Parkinson's disease. Defending her PhD thesis on March 12th, here Shelby tells us about her research within the Developmental and Regenerative Neurobiology research group led by Prof. Malin Parmar and her time spent at Lund Stem Cell Center. Can you tell us about your PhD research? The main focu

https://www.multipark.lu.se/article/phd-defence-interview-shelby-shrigley - 2025-12-29

Alzheimer’s disease seems to progress faster in women than in men. The protein tau accumulates at a higher rate in women, according to research from Lund University in Sweden. The study was recently published in Brain. Over 30 million people suffer from Alzheimer’s disease worldwide, making it the most common form of dementia. Tau and beta-amyloid are two proteins known to aggregate and accumulate

https://www.multipark.lu.se/article/women-accumulate-alzheimers-related-protein-faster - 2025-12-29

In a collaborative study, with other European research groups, scientists from Lund University in Sweden have shed new light on how the protein aggregates that accumulate in the Parkinsonian brain may contribute to neuronal injury during disease progression. The study is published in Cell Reports. The brain is a complex organ composed of billions of neurons, whose proper function is dependent on a

https://www.multipark.lu.se/article/new-insights-toxic-protein-aggregate-formation-parkinsons-disease-size-matters - 2025-12-29

On the last of December, Professor Gunnar Gouras left his position as a coordinator for MultiPark after five years. Here is how he sums up his time and mission for our environment. Can you describe your time as a coordinator for Multipark? To lead Multipark has been very interesting as well as challenging. To have the support from the Swedish government to invest in excellent research is fantastic

https://www.multipark.lu.se/article/interview-gunnar-gouras-about-his-time-coordinator - 2025-12-29

Congratulations to Prof. Malin Parmar, who has been elected as one of three new members of the Board of Directors at the International Society for Stem Cell Research (ISSCR). The Developmental and Regenerative Neurobiology research group led by Prof. Parmar aims to develop new, cell-based therapies for neurodegenerative diseases. Together with her team, Prof. Parmar has shown in a series of pionee

https://www.multipark.lu.se/article/malin-parmar-elected-isscr-board-directors - 2025-12-29

Alzheimer's disease is characterized by the abnormal accumulation and spread of the tau protein in the brain. An international study can now show how tau spreads according to four distinct patterns that lead to different symptoms with different prognoses of the affected individuals. The study was published in Nature Medicine. “In contrast to how we have so far interpreted the spread of tau in the

https://www.multipark.lu.se/article/alzheimers-disease-composed-four-distinct-subtypes - 2025-12-29

On May 11, it is time for the first of a total of six workshops concerning the strategic research areas’ (SRA) work on sustainable development. Sustainability is more than climate and environmental issues. Goal number 3 of the UN global sustainability goals focuses on “good health and well-being”. The workshop series are arranged by the SRA Collegium and Sustainability forum. Within the health-rel

https://www.multipark.lu.se/article/workshop-series-sustainability-effect-research - 2025-12-29

Deep interviews with patients who are at an early stage of Parkinson’s disease show that acceptance was a prerequisite for a maintained life satisfaction despite the disease. The study was conducted by health science researchers from the strategic research area MultiPark at Lund University. People living with Parkinson's disease deal with symptoms and impairments due to the progression of the dise

https://www.multipark.lu.se/article/acceptance-key-life-satisfaction-persons-parkinsons-disease - 2025-12-29

Nine senior researchers from five different faculties at Lund University have been granted three million SEK for a novel transdisciplinary initiative to improve the early diagnosis of Alzheimer’s disease. Four of them are research leaders from the strategic research area MultiPark at the Medical Faculty. The collaboration also involves Region Skåne, Lund Municipality, and several important partner

https://www.multipark.lu.se/article/three-million-new-thematic-collaboration-initiative-about-early-diagnosis-and-prognostics-alzheimers - 2025-12-29

Researchers at Lund University in Sweden have developed an algorithm that combines data from a simple blood test and brief memory tests, to predict with great accuracy who will develop Alzheimer's disease in the future. The findings are published in Nature Medicine. Approximately 20-30% of patients with Alzheimer's disease are wrongly diagnosed within specialist healthcare, and diagnostic work-up

https://www.multipark.lu.se/article/simple-diagnostic-tool-predicts-individual-risk-alzheimers - 2025-12-29

During her Ph.D. studies, Yiyi Yang has been investigating the role of microglia in the pathological development of Alzheimer’s disease. On the 3rd of June, it is time to defend her work supervised by Prof. Tomas Deierborg. Now, Yiyi tells us about her research in the Experimental Neuroinflammation Laboratory as being a part of MultiPark. Can you tell us about your Ph.D. research? The focus of our

https://www.multipark.lu.se/article/phd-defence-interview-yiyi-yang - 2025-12-29

Around 20 000 Swedes are currently suffering from Parkinson’s disease, yet there are still only treatments to alleviate symptoms. Through a new biobank, researchers gain access to the genetic profiles of 1000 Parkinson’s patients together with comprehensive information about their lifestyles and medical histories. “I am convinced that many researchers will use the biobank over the next few years,

https://www.multipark.lu.se/article/new-biobank-provides-insights-parkinsons-disease - 2025-12-29